Scilex Holding Price Target Announced at $14.00/Share by Alliance Global Partners
Scilex Holding Initiated at Buy by Alliance Global Partners
Alliance Global Partners Initiates Coverage On Bitdeer Technologies With Buy Rating, Announces Price Target of $14
Alliance Global Partners Maintains Buy on LiveOne, Lowers Price Target to $1.5
Global Medical REIT Price Target Announced at $12.00/Share by Alliance Global Partners
Global Medical REIT Initiated at Buy by Alliance Global Partners
Alliance Global Partners Initiates Coverage On Euroseas With Buy Rating, Announces Price Target of $60
Alliance Global Partners Maintains Buy on Aspira Womens Health, Lowers Price Target to $5.5
Barinthus Biotherapeutics Price Target Cut to $9.50/Share From $11.00 by Alliance Global Partners
Amplify Energy Price Target Raised to $9.50/Share From $9.00 by Alliance Global Partners
Stifel Maintains Buy on Global Partners, Raises Price Target to $51
Global Partners Analyst Ratings
Alliance Global Partners Initiates Coverage On Alexander & Baldwin With Buy Rating, Announces Price Target of $22
Alliance Global Partners Maintains Buy on Vitesse Energy, Lowers Price Target to $26
Alliance Global Partners Downgrades Rimini Street to Neutral From Buy, Adjusts Price Target to $3 From $4.50
Alliance Global Partners Maintains Buy on Redwire, Raises Price Target to $8.25
Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Raises Price Target to $11
Alliance Global Partners Maintains Buy on Endeavour Silver, Raises Price Target to $5.25
Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8
Alliance Global Partners: Maintains Verastem (VSTM.US) rating, adjusted from buy to buy rating, and adjusted target price from $34.00 to $20.00.